Oshi Health Highlights Reported Cost Savings and Outcomes in Virtual GI Care

According to a recent LinkedIn post from Oshi Health, the company’s 2025 Impact Report highlights outcomes that suggest its virtual gastroenterology model may be delivering strong clinical and economic results at scale. The post cites metrics such as 97% of patients achieving symptom control, a 90% reduction in moderate-to-severe symptoms, and 97% patient satisfaction, alongside an estimated $6,081 annual savings per member based on matched claims analysis.

The company’s LinkedIn post also points to a reported 68% reduction in GI-related emergency room visits and 95% colorectal cancer screening compliance compared with a 59% national figure. For investors, these figures, if sustained and validated by payers and partners, could strengthen Oshi Health’s value proposition to employers and insurers, supporting reimbursement negotiations, contract expansion, and potentially higher lifetime revenue per member in a large, underserved GI care market.

The post frames these results against a backdrop where nearly two-thirds of Americans reportedly experience weekly GI symptoms and two-thirds of U.S. counties lack a gastroenterologist, underscoring a significant access gap. If Oshi Health can continue to convert reported clinical and cost outcomes into scalable commercial relationships, the model may position the company competitively within digital specialty care, though long-term financial impact will depend on customer acquisition costs, retention, and the durability of these outcome metrics.